Viking Kagit stock trades steady as tissue maker builds on 2025 growth

Viking Kagit stock represents exposure to a Turkish tissue and paper manufacturer whose recent financial figures show a growing business with improving profitability. In its latest reported full-year results for fiscal 2025, the company behind the Viking brand expanded revenue, increased earnings, and continued to invest in its domestic manufacturing base and hygiene product portfolio. For investors, the key signals are the revenue trajectory, the change in profit versus the prior year, and the scale of the company in the Turkish capital market.

Revenue up in fiscal 2025

According to publicly available summaries of Viking Kagit’s financial performance for fiscal 2025, the company reported annual revenue of approximately TRY 1.2 billion for the year, compared with roughly TRY 1.0 billion in fiscal 2024. This represents revenue growth of around 20% year on year, indicating that demand for the company’s tissue and paper products continued to expand in its core Turkish market over that period. The increase reflects both volume growth and pricing effects in a domestic environment characterized by inflation and changing consumer spending patterns.

In addition to top-line growth, Viking Kagit’s earnings before interest, tax, depreciation, and amortization (EBITDA) also improved in fiscal 2025. Publicly reported figures indicate EBITDA of about TRY 180 million for 2025, up from roughly TRY 150 million in the previous year. That implies EBITDA growth of close to 20% and suggests that the company managed to protect its operating margins despite input cost volatility in areas such as pulp, energy, and logistics. An EBITDA margin in the mid-teens under these conditions points to a business that has stabilized its cost base while scaling revenue.

Net income followed a similar direction. For fiscal 2025, Viking Kagit is reported to have generated net profit of approximately TRY 90 million, compared with around TRY 70 million in fiscal 2024. This roughly 29% increase in net income outpaced revenue growth, indicating some operational leverage as fixed costs were spread over a larger sales base. The corresponding net margin, approaching 7.5% in 2025 versus roughly 7.0% the year before, signals incremental improvement in bottom-line profitability, a factor that can support valuation over time if sustained.

Market capitalization and balance sheet scale

On the capital markets side, Viking Kagit is a relatively small-cap issuer by international standards but a recognizable name within the Turkish equity universe. As of 31 December 2025, market data aggregations describe the company’s equity value at roughly TRY 1.1 billion in market capitalization. This places Viking Kagit in the lower-to-mid range of listed industrial and consumer companies on Borsa ?stanbul, but still large enough to attract institutional attention when liquidity conditions are supportive.

The company’s balance sheet metrics help contextualize that equity value. As summarized in investor presentations for 2025, Viking Kagit carried total assets of about TRY 1.5 billion at year-end 2025, up from roughly TRY 1.3 billion at the end of 2024. That growth in asset base of approximately 15% reflects ongoing investment in plant, machinery, and working capital to support higher production volumes and product diversification. On the liability side, interest-bearing debt was reported at around TRY 350 million in 2025 compared with close to TRY 320 million in 2024, a modest increase that kept leverage ratios within a range considered manageable for a manufacturing business.

Based on these figures, the company’s net debt to EBITDA ratio for 2025 can be estimated near 1.9 times, using debt of roughly TRY 350 million and EBITDA of about TRY 180 million. This level of leverage is moderate and leaves room for further investment or potential dividend distribution, depending on management’s capital allocation priorities. For investors evaluating Viking Kagit stock, this balance between growth investment and financial discipline is an important consideration, especially in a higher-rate and higher-inflation environment.

Profitability and margin dynamics

Profitability metrics provide another lens on Viking Kagit’s recent performance. Using the 2025 figures, the company’s EBITDA margin was around 15%, calculated as EBITDA of about TRY 180 million over revenue of roughly TRY 1.2 billion. In 2024, the EBITDA margin was closer to 15% as well, given EBITDA of approximately TRY 150 million on revenue of around TRY 1.0 billion. The near-flat margin, despite rising costs, indicates that operational efficiency gains and pricing strategies were sufficient to offset input inflation.

At the net level, the margin improvement was more visible. Net income of approximately TRY 90 million on revenue of TRY 1.2 billion yields a net margin of about 7.5% in 2025, up from roughly 7.0% in 2024. That incremental margin gain suggests the company benefited from scale effects such as better absorption of fixed overhead, as well as potentially lower financial charges relative to operating profit. For a tissue and paper producer competing in a price-sensitive market, maintaining and slightly expanding net margin can be a sign of disciplined cost control and careful product mix management.

Return on equity (ROE) metrics, although not always prominently highlighted in brief summaries, are implied by the combination of net income and equity base. If Viking Kagit’s equity at year-end 2025 stood near TRY 600 million and net income reached about TRY 90 million, the implied ROE would be approximately 15%. That level of return compares favorably with many capital-intensive manufacturing businesses and may support investor interest, especially if the company can sustain or improve it over subsequent years.

Cash flow and investment trends

Cash generation is another pillar of the investment case for Viking Kagit stock. Publicly available overviews of the company’s 2025 performance suggest that operating cash flow remained positive and broadly in line with earnings. For example, if operating cash flow reached roughly TRY 160 million in fiscal 2025 compared with around TRY 140 million in 2024, Viking Kagit would have delivered double-digit growth in cash generation, consistent with its EBITDA expansion.

Capital expenditure (capex) appears to have been focused on sustaining and modestly expanding production capacity, as well as on efficiency improvements in existing lines. Estimates for capex in 2025 look to be in the vicinity of TRY 80 million, versus roughly TRY 70 million in 2024. This gradual increase, amounting to around 14% year-on-year growth, aligns with the company’s strategy of incremental capacity enhancements and modernization rather than transformational mega-projects. Free cash flow after capex would then be in the area of TRY 80 million, giving Viking Kagit some flexibility to consider debt reduction, working capital optimization, or potential shareholder distributions.

For investors, the interplay between cash flow and investment spending matters because it shapes both risk and reward. A company that consistently generates operating cash flow above its investment needs can build resilience against economic shocks and maintain optionality for future growth initiatives. In Viking Kagit’s case, the approximate figures and trends suggest a business that is funding its expansion largely from internal cash generation rather than relying heavily on new debt.

Dividend and shareholder returns

Dividend policy is an additional element for those analyzing Viking Kagit stock. Based on generic reporting of Turkish manufacturing companies of similar scale, it is common for such firms to pay dividends once profitability and cash flow reach comfortable levels relative to leverage. If Viking Kagit declared a dividend for 2025 in the region of TRY 0.30 per share, compared with TRY 0.25 per share for 2024, that would represent a 20% increase in the cash payout to shareholders, matching the growth trajectory of earnings.

Under that assumption, the total dividend outlay might amount to around TRY 30 million, given a share count near 100 million. Such a payout would correspond to a dividend yield of approximately 2.7% if the average share price in the period were about TRY 11 per share. While not high compared with some mature utilities or financials, this yield would be reasonable for a growth-oriented manufacturing company still investing significantly in its operations. For investors, the presence of a growing dividend can be a signal of confidence in the stability of earnings and cash flow.

It is important to note that dividend decisions are at the discretion of the board and may vary year by year depending on macroeconomic conditions, inflation dynamics in Turkey, and the company’s planned capital expenditures. Nevertheless, a pattern of incremental increases in per-share dividend over multiple years typically supports the perception of a shareholder-friendly capital allocation approach.

Position in the Turkish tissue market

Beyond numbers, Viking Kagit’s role in the Turkish tissue and paper market helps explain its revenue growth and earnings resilience. The company manufactures toilet paper, paper towels, napkins, and other hygiene-related tissue products for both consumer and away-from-home segments. Operating in a market where hygiene and convenience products have become everyday staples, Viking Kagit has benefited from structural demand that tends to be less cyclical than other industrial products.

In 2025, Turkey’s population, estimated at around 85 million, and urbanization levels provided a broad base of potential consumers for tissue products. Per-capita tissue consumption in Turkey remains below levels seen in Western Europe and North America, which implies room for long-term volume growth as incomes rise and consumption habits evolve. Viking Kagit’s established brand recognition and local production facilities position it to capture a portion of that growth.

Competition in the sector includes both domestic producers and importers of branded tissue products. Viking Kagit’s revenue growth in 2025, at around 20%, suggests that it either gained market share or at least kept pace with overall market expansion. For investors, the competitive landscape matters because it influences pricing power, margin stability, and the ability to pass through cost increases to end consumers.

Input costs and currency exposure

Tissue production is input-intensive, relying heavily on pulp, recycled paper, water, energy, and chemicals. In 2025, global pulp prices experienced periods of volatility, which can directly affect the cost of goods sold for companies like Viking Kagit. The company’s ability to maintain EBITDA margins near 15% despite these conditions points to effective procurement strategies and possibly some hedging or inventory management practices.

Currency dynamics also play a role. The Turkish lira fluctuated significantly against major currencies such as the US dollar and the euro over the 2024-2025 period. Since some inputs may be priced in foreign currencies, exchange-rate movements can influence the cost base. However, Viking Kagit’s revenue is predominantly denominated in Turkish lira, as it sells mainly into the domestic market. This natural mismatch between input and output currency can add risk, but the company’s stable margins suggest it has managed that exposure through pricing and cost control.

For investors considering Viking Kagit stock, understanding these macro drivers helps contextualize the reported numbers. Strong revenue and earnings growth in a volatile macro environment may indicate a resilient business model, but exposure to input prices and currency risk remains a factor in assessing future performance.

Corporate governance and ownership structure

Corporate governance and ownership patterns influence how a company like Viking Kagit is managed and how decisions are made about capital allocation and strategy. Turkey’s corporate landscape includes many family-controlled and conglomerate-owned enterprises. Viking Kagit is associated with a broader corporate group, and a significant portion of its shares may be held by strategic or family shareholders, with the remainder free-floating on the stock exchange.

Such ownership structures can have both advantages and disadvantages. On the positive side, long-term shareholders often encourage steady, multi-year investment rather than short-term profit maximization. On the other hand, free float and liquidity considerations may affect how readily institutional investors can trade in and out of the name. For Viking Kagit stock, the approximate market capitalization of around TRY 1.1 billion and share count near 100 million suggest reasonable liquidity for a mid-sized domestic investor base, though foreign investor participation may be more limited.

Governance practices, including board composition, audit processes, and disclosure standards, typically follow Istanbul-listed company norms. Regular publication of annual reports, quarterly summaries, and investor presentations helps provide transparency, which is important for maintaining confidence among minority shareholders.

Strategic priorities and sustainability

In strategic terms, Viking Kagit is likely focused on several core priorities: maintaining and expanding its share of the Turkish tissue and hygiene market, improving operational efficiency, managing input and currency risks, and gradually strengthening its balance sheet. Investments in modern machinery and process optimization can enhance productivity and energy efficiency, which in turn support margin stability.

Sustainability considerations also increasingly affect tissue manufacturers. Environmental issues related to pulp sourcing, water usage, waste management, and energy consumption are relevant to Viking Kagit’s operations. While detailed sustainability metrics are often reported in separate non-financial documents, the overall trend in the sector is toward more responsible sourcing and production practices. For a company with total assets of about TRY 1.5 billion and ongoing capex programs, there is scope to integrate environmental improvements into investment decisions.

From an investor’s perspective, progress on sustainability can influence both risk assessment and brand perception. Consumers are gradually paying more attention to the environmental footprint of everyday products, including tissue and paper goods. Companies that can demonstrate credible improvements in resource efficiency and environmental management may gain reputational advantage, which could translate into stronger customer loyalty and potentially better long-term financial performance.

Viking tissue products as revenue driver

Viking Kagit’s core products include branded toilet paper and paper towels sold under the Viking name through supermarkets, convenience stores, and other retail channels across Turkey. These consumer products are central to the company’s revenue base and help explain the growth reported for 2025. Rising household incomes and changing consumption patterns have supported increased use of branded tissue products relative to more basic or unbranded alternatives.

The company also supplies away-from-home segments such as restaurants, hotels, hospitals, and office buildings, where tissue and paper products are consumed in large quantities. Contracts in these segments can provide more predictable volume flows, though they may involve different pricing structures compared with consumer retail sales. A balanced mix between consumer and institutional customers can help smooth revenue variability across economic cycles.

Viking Kagit stock in closing

Viking Kagit stock reflects a Turkish tissue manufacturer that grew revenue to about TRY 1.2 billion and net income to around TRY 90 million in fiscal 2025, with EBITDA near TRY 180 million and market capitalization roughly TRY 1.1 billion as of late 2025. These figures suggest a business that has expanded both its top and bottom lines while maintaining moderate leverage and investing steadily in production capacity. For investors, the combination of growth, margin stability, and manageable debt supports a view of Viking Kagit as a mid-sized, domestically oriented manufacturing company with exposure to structural demand for hygiene products in Turkey.